COSCIENS Biopharma, Inc. (CSCI.TO)
8.62
0.00 (0.00%)
CAD |
TSX |
Oct 23, 16:00
COSCIENS Biopharma Enterprise Value : 4.436M for Oct. 23, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 4.436M |
| October 22, 2026 | 4.436M |
| October 21, 2026 | 4.436M |
| October 20, 2026 | 4.415M |
| October 19, 2026 | 4.606M |
| October 16, 2026 | 5.009M |
| October 15, 2026 | 4.733M |
| October 14, 2026 | 5.476M |
| October 13, 2026 | 5.582M |
| October 09, 2026 | 5.476M |
| October 08, 2026 | 5.784M |
| October 07, 2026 | 5.031M |
| October 06, 2026 | 4.521M |
| October 05, 2026 | 4.712M |
| October 02, 2026 | 4.574M |
| October 01, 2026 | 4.574M |
| September 30, 2026 | 5.105M |
| September 29, 2026 | 5.105M |
| September 28, 2026 | 4.415M |
| September 25, 2026 | 4.415M |
| September 24, 2026 | 4.192M |
| September 23, 2026 | 3.778M |
| September 22, 2026 | 3.778M |
| September 21, 2026 | 3.247M |
| September 18, 2026 | 3.354M |
| Date | Value |
|---|---|
| September 17, 2026 | 3.194M |
| September 16, 2026 | 3.194M |
| September 15, 2026 | 3.194M |
| September 14, 2026 | 3.407M |
| September 11, 2026 | 3.407M |
| September 10, 2026 | 3.364M |
| September 09, 2026 | 3.364M |
| September 08, 2026 | 3.364M |
| September 04, 2026 | 3.141M |
| September 03, 2026 | 3.141M |
| September 02, 2026 | 3.247M |
| September 01, 2026 | 2.982M |
| August 31, 2026 | 3.035M |
| August 28, 2026 | 3.035M |
| August 27, 2026 | 3.035M |
| August 26, 2026 | 3.035M |
| August 25, 2026 | 3.247M |
| August 24, 2026 | 2.971M |
| August 21, 2026 | 3.035M |
| August 20, 2026 | 3.725M |
| August 19, 2026 | 3.714M |
| August 18, 2026 | 3.078M |
| August 17, 2026 | 3.651M |
| August 14, 2026 | 3.651M |
| August 13, 2026 | 3.630M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Spectral Medical, Inc. | 317.48M |
| Resverlogix Corp. | 139.42M |
| Theratechnologies, Inc. | -- |
| Restart Life Sciences Corp. | 3.951M |
| Defence Therapeutics Inc | 28.09M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.2796M |
| Revenue (Quarterly) | 4.351M |
| Total Expenses (Quarterly) | 4.631M |
| EPS Diluted (Quarterly) | -0.267 |
| Gross Profit Margin (Quarterly) | 55.27% |
| Profit Margin (Quarterly) | -6.43% |
| Earnings Yield | -71.97% |
| Normalized Earnings Yield | -75.90 |